Review




Structured Review

Perspectum Diagnostics Ltd liver multiscan tm software
Liver Multiscan Tm Software, supplied by Perspectum Diagnostics Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/liver+multiscan+ideal+algorithm/livermultiscan+software/pmc05494094-79-9-13
Average 90 stars, based on 1 article reviews
liver multiscan tm software - by Bioz Stars, 2026-11
90/100 stars

Images

Related Articles

Magnetic Resonance Imaging:

Article Title: Accuracy of Non‐Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD : A Systematic Review
Article Snippet: MRI‐PDFF , Compares the fat and water components of an MRI scan, and expresses as a percentage , Detects increased steatosis, which could be a marker of increased risk of MASH. Positive correlations between change in MRI‐PDFF and steatosis grade have been demonstrated [ , ] . .. MpMRI , Combines different MRI techniques into a single scan. T1 mapping detects increases in extracellular fluid. Hepatic iron can be a confounding factor. Therefore, iron is calculated with parallel acquisition of T2. Iron‐corrected T1 relaxation maps (cT1) take out this confounding factor , cT1 or T1 mapping correlates with fibrosis and inflammation. Inflammation creates increases in extracellular fluid detected by the scan [ ] Liver MultiScan Software ( Perspectum, Oxford, UK) postprocesses non‐contrast MpMRI imaging scans to simultaneously quantify steatosis (via MRI‐PDFF), fibrosis and inflammation (via cT1) . .. GA‐MRI , Gadoxetic acid is a hepatobiliary contrast agent that is taken up by the hepatocytes, allowing more detailed interpretation of liver anatomy , The hepatobiliary phase T1 relaxation time potentially differentiates MASH from steatosis. Amorim et al. hypothesise that expression of the multidrug resistance protein transporter is increased in patients with MASH, causing an increase in GA excretion with a consequent decrease in signal intensity [ ]. Bastati et al. hypothesise the reduction in signal intensity is due to liver injuries reducing hepatosinusoidal space and thus GA uptake [ ] .

Article Title: Quantitative MRI for Monitoring Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Test–Retest Repeatability Study
Article Snippet: .. The specific MRI protocol used has been described elsewhere. cT1 and fat fraction maps were generated using commercially available software (LiverMultiScan, Perspectum). ..

Article Title: Accuracy of Non-Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD: A Systematic Review.
Article Snippet: .. Inflammation creates increases in extracellular fluid detected by the scan [64] • LiverMultiScan Software (Perspectum, Oxford, UK) postprocesses non- contrast MpMRI imaging scans to simultaneously quantify steatosis (via MRI- PDFF), fibrosis and inflammation (via cT1) GA- MRI Gadoxetic acid is a hepatobiliary contrast agent that is taken up by the hepatocytes, allowing more detailed interpretation of liver anatomy The hepatobiliary phase T1 relaxation time potentially differentiates MASH from steatosis. ..

Article Title: Machine learning uncovers manganese as a key nutrient associated with reduced risk of steatotic liver disease.
Article Snippet: .. The PDFF was calculated from the MRI images using the LiverMultiScan software (Perspectum Ltd, Oxford, UK) and was extracted from the UK biobank website (UKB field ID 40061). ..

Article Title: NAFLD (MASLD)/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review
Article Snippet: .. The LiverMultiScan utilizes MRI-based imaging software (LiverMultiScan|Perspectum, https://www.perspectum.com/our-products/livermultiscan (accessed on 29 July 2024)) to provide a precise measurement of liver fat content and an indirect evaluation of fibrosis. ..

Software:

Article Title: Accuracy of Non‐Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD : A Systematic Review
Article Snippet: MRI‐PDFF , Compares the fat and water components of an MRI scan, and expresses as a percentage , Detects increased steatosis, which could be a marker of increased risk of MASH. Positive correlations between change in MRI‐PDFF and steatosis grade have been demonstrated [ , ] . .. MpMRI , Combines different MRI techniques into a single scan. T1 mapping detects increases in extracellular fluid. Hepatic iron can be a confounding factor. Therefore, iron is calculated with parallel acquisition of T2. Iron‐corrected T1 relaxation maps (cT1) take out this confounding factor , cT1 or T1 mapping correlates with fibrosis and inflammation. Inflammation creates increases in extracellular fluid detected by the scan [ ] Liver MultiScan Software ( Perspectum, Oxford, UK) postprocesses non‐contrast MpMRI imaging scans to simultaneously quantify steatosis (via MRI‐PDFF), fibrosis and inflammation (via cT1) . .. GA‐MRI , Gadoxetic acid is a hepatobiliary contrast agent that is taken up by the hepatocytes, allowing more detailed interpretation of liver anatomy , The hepatobiliary phase T1 relaxation time potentially differentiates MASH from steatosis. Amorim et al. hypothesise that expression of the multidrug resistance protein transporter is increased in patients with MASH, causing an increase in GA excretion with a consequent decrease in signal intensity [ ]. Bastati et al. hypothesise the reduction in signal intensity is due to liver injuries reducing hepatosinusoidal space and thus GA uptake [ ] .

Article Title: Quantitative MRI for Monitoring Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Test–Retest Repeatability Study
Article Snippet: .. The specific MRI protocol used has been described elsewhere. cT1 and fat fraction maps were generated using commercially available software (LiverMultiScan, Perspectum). ..

Article Title: Accuracy of Non-Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD: A Systematic Review.
Article Snippet: .. Inflammation creates increases in extracellular fluid detected by the scan [64] • LiverMultiScan Software (Perspectum, Oxford, UK) postprocesses non- contrast MpMRI imaging scans to simultaneously quantify steatosis (via MRI- PDFF), fibrosis and inflammation (via cT1) GA- MRI Gadoxetic acid is a hepatobiliary contrast agent that is taken up by the hepatocytes, allowing more detailed interpretation of liver anatomy The hepatobiliary phase T1 relaxation time potentially differentiates MASH from steatosis. ..

Article Title: Machine learning uncovers manganese as a key nutrient associated with reduced risk of steatotic liver disease.
Article Snippet: .. The PDFF was calculated from the MRI images using the LiverMultiScan software (Perspectum Ltd, Oxford, UK) and was extracted from the UK biobank website (UKB field ID 40061). ..

Article Title: A fasting-mimicking diet programme reduces liver fat and liver inflammation/fibrosis measured by magnetic resonance imaging in patients with type 2 diabetes.
Article Snippet: .. After image acquisition, pseudonymized data were analysed off-site using LiverMultiScan software (Perspectum Ltd., Oxford, United Kingdom) by specialized imaging analysts trained in abdominal anatomy and artefact detection, who were blinded to group allocation. ..

Article Title: NAFLD (MASLD)/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review
Article Snippet: .. The LiverMultiScan utilizes MRI-based imaging software (LiverMultiScan|Perspectum, https://www.perspectum.com/our-products/livermultiscan (accessed on 29 July 2024)) to provide a precise measurement of liver fat content and an indirect evaluation of fibrosis. ..

Article Title: Quantitative MRI for Monitoring Metabolic Dysfunction-Associated Steatotic Liver Disease: A Test-Retest Repeatability Study.
Article Snippet: .. See the T erm s and C onditions (https://onlinelibrary.w iley.com /term s-and-conditions) on W iley O nline L ibrary for rules of use; O A articles are governed by the applicable C reative C om m ons L icense elsewhere.29 cT1 and fat fraction maps were generated using commercially available software (LiverMultiScan, Perspectum). ..

Article Title: Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank.
Article Snippet: .. Liver images were analysed using LiverMultiScanTM Discover software (Perspectum Diagnostics) to obtain measures of liver fat % and MR echoes used to create PDFF maps using a three-point DIXON technique [21]. ..

Imaging:

Article Title: Accuracy of Non‐Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD : A Systematic Review
Article Snippet: MRI‐PDFF , Compares the fat and water components of an MRI scan, and expresses as a percentage , Detects increased steatosis, which could be a marker of increased risk of MASH. Positive correlations between change in MRI‐PDFF and steatosis grade have been demonstrated [ , ] . .. MpMRI , Combines different MRI techniques into a single scan. T1 mapping detects increases in extracellular fluid. Hepatic iron can be a confounding factor. Therefore, iron is calculated with parallel acquisition of T2. Iron‐corrected T1 relaxation maps (cT1) take out this confounding factor , cT1 or T1 mapping correlates with fibrosis and inflammation. Inflammation creates increases in extracellular fluid detected by the scan [ ] Liver MultiScan Software ( Perspectum, Oxford, UK) postprocesses non‐contrast MpMRI imaging scans to simultaneously quantify steatosis (via MRI‐PDFF), fibrosis and inflammation (via cT1) . .. GA‐MRI , Gadoxetic acid is a hepatobiliary contrast agent that is taken up by the hepatocytes, allowing more detailed interpretation of liver anatomy , The hepatobiliary phase T1 relaxation time potentially differentiates MASH from steatosis. Amorim et al. hypothesise that expression of the multidrug resistance protein transporter is increased in patients with MASH, causing an increase in GA excretion with a consequent decrease in signal intensity [ ]. Bastati et al. hypothesise the reduction in signal intensity is due to liver injuries reducing hepatosinusoidal space and thus GA uptake [ ] .

Article Title: Accuracy of Non-Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD: A Systematic Review.
Article Snippet: .. Inflammation creates increases in extracellular fluid detected by the scan [64] • LiverMultiScan Software (Perspectum, Oxford, UK) postprocesses non- contrast MpMRI imaging scans to simultaneously quantify steatosis (via MRI- PDFF), fibrosis and inflammation (via cT1) GA- MRI Gadoxetic acid is a hepatobiliary contrast agent that is taken up by the hepatocytes, allowing more detailed interpretation of liver anatomy The hepatobiliary phase T1 relaxation time potentially differentiates MASH from steatosis. ..

Article Title: NAFLD (MASLD)/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review
Article Snippet: .. The LiverMultiScan utilizes MRI-based imaging software (LiverMultiScan|Perspectum, https://www.perspectum.com/our-products/livermultiscan (accessed on 29 July 2024)) to provide a precise measurement of liver fat content and an indirect evaluation of fibrosis. ..

Generated:

Article Title: Quantitative MRI for Monitoring Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Test–Retest Repeatability Study
Article Snippet: .. The specific MRI protocol used has been described elsewhere. cT1 and fat fraction maps were generated using commercially available software (LiverMultiScan, Perspectum). ..

Article Title: Quantitative MRI for Monitoring Metabolic Dysfunction-Associated Steatotic Liver Disease: A Test-Retest Repeatability Study.
Article Snippet: .. See the T erm s and C onditions (https://onlinelibrary.w iley.com /term s-and-conditions) on W iley O nline L ibrary for rules of use; O A articles are governed by the applicable C reative C om m ons L icense elsewhere.29 cT1 and fat fraction maps were generated using commercially available software (LiverMultiScan, Perspectum). ..

Fat:

Article Title: Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank.
Article Snippet: .. Liver images were analysed using LiverMultiScanTM Discover software (Perspectum Diagnostics) to obtain measures of liver fat % and MR echoes used to create PDFF maps using a three-point DIXON technique [21]. ..



Similar Products

90
Perspectum Diagnostics Ltd liver multiscan ideal algorithm
Liver Multiscan Ideal Algorithm, supplied by Perspectum Diagnostics Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/liver+multiscan+ideal+algorithm/livermultiscan/pm34373137-112-5-15
Average 90 stars, based on 1 article reviews
liver multiscan ideal algorithm - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results